Пути развития иммунотерапии колоректального ракаIn colorectal
cancer immunotherapy, the use of antibodies against the PD-1/PD-L1 checkpoints showed
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) -specific macrophages and from newly recruited monocytes. TAMs’ variability strongly depends on
cancer type, stage
ИММУНОТЕРАПИЯ ГЕПАТОЦЕЛЛЮЛЯРНОГО РАКА В РЕСПУБЛИКЕ БАШКОРТОСТАНIMMUNOTHERAPY OF HEPATOCELLULAR
CANCER IN THE REPUBLIC OF BASHKORTOSTAN